Using Xenopus to discover new genes involved in Branchiootorenal spectrum disorders.

TitleUsing Xenopus to discover new genes involved in Branchiootorenal spectrum disorders.
Publication TypeJournal Article
Year of Publication2015
AuthorsMoody SA, Neilson KM, Kenyon KL, Alfandari D, Pignoni F
JournalComp Biochem Physiol C Toxicol Pharmacol
Date Published2015 Jun 24
ISSN1532-0456
Abstract

Congenital hearing loss is an important clinical problem because, without early intervention, affected children do not properly acquire language and consequently have difficulties developing social skills. Although most newborns in the US are screened for hearing deficits, even earlier diagnosis can be made with prenatal genetic screening. Genetic screening that identifies the relevant mutated gene can also warn about potential congenital defects in organs not related to hearing. We will discuss efforts to identify new candidate genes that underlie the Branchiootorenal spectrum disorders in which affected children have hearing deficits and are also at risk for kidney defects. Mutations in two genes, SIX1 and EYA1, have been identified in about half of the patients tested. To uncover new candidate genes, we have used the aquatic animal model, Xenopus laevis, to identify genes that are part of the developmental genetic pathway of Six1 during otic and kidney development. We have already identified a large number of potential Six1 transcriptional targets and candidate co-factor proteins that are expressed at the right time and in the correct tissues to interact with Six1 during development. We discuss the advantages of using this system for gene discovery in a human congenital hearing loss syndrome.

DOI10.1016/j.cbpc.2015.06.007
Alternate JournalComp. Biochem. Physiol. C Toxicol. Pharmacol.
Refereed DesignationRefereed
PubMed ID26117063